Study Establishes Feasibility of Reduced-Dose IMRT Plus Cisplatin in Good-Risk HPV-Associated OPSCC
Investigators tested the efficacy of reduced-dose radiation plus cisplatin in patients with good-risk human papillomavirus–associated oropharyngeal squamous cell carcinoma (OPSCC).